Pharmaceuticals, Biotechnology and Life Sciences
Potentially pivotal trial for industry’s most-advanced cell-based therapy in severe liver diseases expected to generate results in H2 2023 MONT-SAINT-GUIBERT,…
LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext: POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic…
Ark to Showcase Anti-Viral and Respiratory Pipeline SHANGHAI–(BUSINESS WIRE)–Ark Biosciences, a global biotech company developing groundbreaking therapeutics for viral infection…
MENLO PARK, Calif.–(BUSINESS WIRE)–#immunotherapy–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of the…
REDMOND, Wash.–(BUSINESS WIRE)–#HealthOutcomes—Curadite, Inc., an award-winning, platform-based medication management innovator, announced today that it has been selected to participate in…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President…
— Presentation to be webcast on www.exelixis.com — ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey,…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global malignant mesothelioma therapeutics market is poised to grow by USD 133.81 million during 2019-2023, progressing at a…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, announced the full exercise of the over-allotment…
Enrollment of PR+ ovarian cancer trial on track, initial data in 2020 Program update on onapristone ER in hormone positive…